Wed.Sep 06, 2023

article thumbnail

MorningRX: September 6, 2023

Drug Topics

The CDC issues an alert for increased RSV activity, a survey finds men's habits don't stack up to their perceptions on their health, and the WHO announces an air pollution training course for health care workers.

281
281
article thumbnail

Why this scientist left Janssen to help ‘revolutionize’ small molecule drug discovery

PharmaVoice

Murray McKinnon, CSO of Empress Therapeutics, believes its drug discovery platform holds the key to treating and detecting many diseases.

243
243
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Moderna’s Updated COVID-19 Vaccine Effective Against BA.2.86 Variant

Drug Topics

Previous clinical data has shown that the vaccine also generates a strong response to the EG.5 and FL.1.5.1 variants.

Vaccines 281
article thumbnail

STAT+: South Africa was forced into ‘one-sided’ deals with Covid-19 vaccine suppliers, contracts reveal

STAT

South Africa was “bullied” into signing one-sided contracts with Covid-19 vaccine suppliers that forced the government to pay more than the European Union but offered little protection against delivery failures, according to an advocacy group. For instance, Johnson & Johnson charged South Africa $10 a dose, 15% more than the company charged the European Union, while the government was required to pay a non-refundable down payment of $27.5 million.

Vaccines 143
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

FDA Issues Tentative Approval to Abacavir/Dolutegravir/Lamivudine Combo to Treat HIV in Pediatric Patients

Pharmacy Times

The fixed-dose abacavir/dolutegravir/lamivudine combination is indicated for the once-daily treatment of children weighing at least 6 kg to <25 kg with HIV-1 infection.

FDA 139
article thumbnail

STAT+: Covid hospitalizations on the rise, Humana says

STAT

More older adults have been hospitalized for Covid-19 over the past several weeks, according to internal data reviewed by health insurance giant Humana. Humana, which mostly provides health insurance to those 65 and older and who are therefore more vulnerable to the worst effects of Covid, expected more Covid cases and hospitalizations this year. But it didn’t expect the uptick to come during the waning summer months.

Hospitals 140

More Trending

article thumbnail

Opinion: I cured my ARFID with psilocybin. I shouldn’t have needed to self-treat it

STAT

For 27 years, I tried to make myself eat vegetables. Last fall, I ate my first salad. Since I was 2 years old, I had an eating disorder known as ARFID — avoidant/restrictive food intake disorder. After an infant ear surgery, I mysteriously could only tolerate bread and cheese. Every other food made me gag. A ripe orange, for example, smelled like rotting flesh.

140
140
article thumbnail

More than half of Americans are unfamiliar with chronic kidney disease, survey finds

Fierce Healthcare

Chronic kidney disease (CKD) is a major blind spot for many Americans, a new survey suggests. | Though many respondents used the internet for medical information and had a regular doctor and blood work done once or twice a year, 58% of respondents were unfamiliar with the illness.

132
132
article thumbnail

With affirmative action off the table, medical schools plan new diversity tactics

STAT

“Lots of scrambling on the ground.” That’s how Consuelo Wilkins, the senior associate dean for health equity and inclusive excellence at Vanderbilt University Medical Center, describes medical schools’ current efforts to maintain diversity in the wake of the U.S. Supreme Court’s decision to strike down affirmative action based on race.

article thumbnail

YouTube expanding health videos to more diverse audiences with new content creator, AI dubbing programs

Fierce Healthcare

YouTube announced two programs Thursday that the Google-owned video platform said will give healthcare content creators new opportunities to educate diverse audiences. | The two new initiatives leverage cultural representation and targeted messaging to reach audiences impacted by health inequity, Google's Garth Graham, M.D., said.

131
131
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Robert Winn: Without ‘high-touch’ strategies, cancer’s breakthroughs will increase disparities

STAT

Looking at the dizzying progress in cancer medicine over the last couple of decades, it’s easy to imagine that advances in synthetic biology or immunology will soon help cure or prevent more cancers. But without a strategy to connect “these miracles” to all communities, only some will benefit and others will be left behind, said Robert Winn, the director of the Massey Cancer Center at Virginia Commonwealth University.

135
135
article thumbnail

J&J's patient assistance program suffers data breach, IBM says

Fierce Pharma

IBM disclosed "unauthorized access" to J&J’s Janssen CarePath patient assistance program, which helped over 1 million U.S. patients last year.

128
128
article thumbnail

Opinion: What does ‘bona fide competition’ actually mean in the biologics market?

STAT

On Aug. 29, Medicare released its highly anticipated list of 10 therapies for which it plans to establish a price by 2026. The Inflation Reduction Act (IRA), passed in August 2022, gives Medicare pricing power over therapies that both cost Medicare lots of money and have by 2026 enjoyed market exclusivity for a certain number of years — nine for small-molecule drugs and 13 for biologics.

135
135
article thumbnail

Hospitals push FTC to withdraw 'largely unnecessary' updates to pre-merger regulatory filings

Fierce Healthcare

The American Hospital Association (AHA) is among those pushing back against the Federal Trade Commission’s (FTC's) plans to update pre-merger notification requirements, calling the proposal “a subs | "There is no need to subject hospitals to burdensome rules aimed at other sectors of the economy,” the AHA wrote of amendments to the Hart-Scott-Rodino Form proposed in June.

Hospitals 124
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

STAT+: Cancer care appears brighter as off-the-shelf CAR-T advances

STAT

If you ask biopharma leaders what’s ahead for CAR-T cancer therapy, they say the future is bright. And that future will also look markedly different than it does today, three of them said at the STAT 2023 Future Summit on Wednesday. Now in its second decade, the cell therapy — which attacks cancer by extracting white blood cells from a patient, genetically modifying them, and then re-infusing them to fight the cancer — has made remarkable strides.

132
132
article thumbnail

Phase 3 Trial Results Show Tisotumab-Vedotin Improved OS in Adult Patients With Recurrent or Metastatic Cervical Cancer

Pharmacy Times

In addition to overall survival, main efficacy outcomes, such as progression-free survival, objective response rate, and time to response, were compared to chemotherapy alone.

article thumbnail

STAT+: House committees strike deal on health transparency, PBM reform package

STAT

WASHINGTON — Republicans on three key House committees have reconciled their differing legislative packages to increase transparency in the health care system and reform payment practices for both pharmacy middlemen and hospitals, according to a bill draft obtained by STAT. The committees, the House Energy and Commerce Committee, the Ways and Means Committee, and the Committee on Education and the Workforce are planning to introduce the legislation formally on Friday, per an email obtaine

Packaging 129
article thumbnail

Research Seeks to Aid Management of Type 2 Diabetes Through Dietary Education

Pharmacy Times

An upcoming large-scale clinical trial of the Glucose Everyday Matters program will evaluate its safety and efficacy in managing type 2 diabetes.

123
123
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

FDA starts review of Roche's PNH drug crovalimab

pharmaphorum

FDA starts review of Roche's PNH drug crovalimab Phil.

FDA 116
article thumbnail

Study: Blood Cancer Treatment Found to Kill Latent HIV-Infected Cells, Possible New Treatment

Pharmacy Times

Although antiretroviral therapies are the standard of care treatment for those with HIV, the drugs cannot target latent infections; however, venetoclax, a blood cancer treatment, shows promise.

123
123
article thumbnail

Huge decline in spending on Medicare begs the question: Why?

Fierce Healthcare

Research shows that Medicare spending has leveled off for the past decade, morphing from something that experts worried might break the federal budget to an unexpected bright spot. | Medicare had once been seen as something that would one day break the budget. However, Medicare spending in the last decade slowed greatly. But why?

115
115
article thumbnail

Clinical Overview: Opill as First OTC Contraception in United States

Pharmacy Times

Norgestrel (Opill) for pregnancy prevention will be accessible at various retail locations, including drug stores, convenience stores, grocery stores, and online platforms.

article thumbnail

STAT+: Pharmalittle: Novartis is losing its chief commercial officer; vaccine experts urge more inclusivity in clinical trials

STAT

Top of the morning to you. And a steamy one, it is. In fact, there is more steam rising from the grounds of the Pharmalot campus than from our ritual cup of stimulation (which happens to be coconut rum today). But this is to be expected at this time of year, yes? In any event, there is work to be done, so as always, we have assembled a few items of interest for you.

Vaccines 112
article thumbnail

Revolution Beauty brings skin care collection to Walgreens

Drug Store News

The brand’s Revolution Skincare Pro Miracle Cream and Revolution Skincare Pro Miracle Eye Cream will be available at the retailer.

111
111
article thumbnail

Why pharmacies are turning to route optimisation

pharmaphorum

Why pharmacies are turning to route optimisation Mike.

111
111
article thumbnail

Lactation coverage advocates say ACA mandate is still not enforced

Fierce Healthcare

When the Affordable Care Act (ACA) was passed in 2010, the legislation set forth requirements for insurers to cover lactation services for mothers, a stark contrast from expecting families to pay o | The Affordable Care Act says insurance companies must front the cost for lactation care. Many are still not doing so, forcing other providers to step up.

Insurance 110
article thumbnail

Biofourmis quietly parts company with CEO Rajput

pharmaphorum

Biofourmis quietly parts company with CEO Rajput Phil.

110
110
article thumbnail

Genuine Health Group brings on former UHC executive as it charts future growth

Fierce Healthcare

Former UnitedHealthcare executive Roger Rodriguez said that during his tenure with the insurance giant, he endeavored to view payer issues through a provider lens. | Former UnitedHealthcare executive Roger Rodriguez said that during his tenure with the insurance giant, he endeavored to view payer issues through a provider lens.

Insurance 109
article thumbnail

What is the future for technicians?

Drug Store News

Pharmacy technicians are crucial to the accessibility and continuity of healthcare.

106
106
article thumbnail

8 ways to stop a runny nose

The Checkup by Singlecare

A runny nose isn’t usually serious, but that doesn’t mean it isn’t bothersome or uncomfortable. A runny nose can cause congestion , make breathing more difficult, interrupt sleep, and may be accompanied by other annoying symptoms like coughing and sneezing. If you’re dealing with these issues, you probably want some relief. Many simple remedies for runny noses include at-home treatments like hot compresses, steam treatments, and over-the-counter medications like antihistamines and decongestant

article thumbnail

C&S, SoftBank reportedly close to deal to purchase stores from Kroger, Albertsons

Drug Store News

C&S could announce the deal to acquire most or all of the stores that Albertsons and Kroger are divesting for antitrust reasons as soon as this week, per a Bloomberg report.

106
106
article thumbnail

J&J pulls out of Idorsia deal for hypertension drug

pharmaphorum

J&J pulls out of Idorsia deal for hypertension drug Phil.

105
105
article thumbnail

HDA 2023 Traceability Seminar: A Status Update

Pharmaceutical Commerce

Stakeholders uncover the obstacles surrounding the industry onboarding process.

105
105